Global Evidence & Value Development - R&D, Merck Healthcare KGaA, Darmstadt, Germany.
Institute of Medicines Development, Cardiff, UK.
Neurodegener Dis Manag. 2024 Feb;14(1):5-9. doi: 10.2217/nmt-2023-0034. Epub 2024 Mar 19.
WHAT IS THIS SUMMARY ABOUT?: This summary explains the findings of a recent study that compared different questionnaires used by doctors to measure levels of fatigue in people with multiple sclerosis (MS). The aim of the study was to find out which questionnaire doctors should use to measure fatigue in people with MS in the future. Fatigue, which can be described as the overwhelming feeling of tiredness or exhaustion, is a very common symptom of MS. For the majority of people with MS, fatigue is one of the worst symptoms of MS, so it is essential that doctors can measure it accurately. Currently, people with MS are asked to complete questionnaires so that their care team can see the effect of fatigue on their day-to-day lives. There are many questionnaires that are used to measure fatigue in people with MS. It would be valuable to come to an agreement, based on evidence from research like this study, on which questionnaire is the most appropriate for measuring fatigue in both research and healthcare settings. This study compared a questionnaire called the PROMIS Fatigue (MS) 8a, referred to throughout this summary as the PROMIS MS Fatigue Short Form, with two of the most commonly used questionnaires: the Fatigue Severity Scale (FSS) and the Modified Fatigue Impact Scale (MFIS). The questionnaires were compared to see which one should be recommended to doctors for measuring fatigue in people with MS.
WHAT ARE THE KEY TAKEAWAYS?: It was found that while all three questionnaires were good, the PROMIS MS Fatigue Short Form questionnaire was better than the other two questionnaires at showing differences in levels of fatigue between people with MS. The PROMIS MS Fatigue Short Form was also found to be better than the Fatigue Severity Scale (FSS) at showing changes in the person with MS's level of fatigue. The PROMIS MS Fatigue Short Form questionnaire may help people with MS to better communicate challenges with their fatigue to their doctors.
WHAT WAS THE MAIN CONCLUSION REPORTED BY THE RESEARCHERS?: The study suggests that the PROMIS MS Fatigue Short Form questionnaire is a helpful tool for doctors and people with MS to measure fatigue.
本摘要解释了一项最近的研究结果,该研究比较了医生用于衡量多发性硬化症(MS)患者疲劳程度的不同问卷。该研究的目的是找出医生在未来应使用哪种问卷来衡量 MS 患者的疲劳。疲劳是一种常见的 MS 症状,可以被描述为压倒性的疲劳或疲惫感。对于大多数 MS 患者来说,疲劳是 MS 最严重的症状之一,因此医生能够准确测量疲劳至关重要。目前,要求 MS 患者填写问卷,以便他们的护理团队可以了解疲劳对他们日常生活的影响。有许多问卷可用于衡量 MS 患者的疲劳程度。基于这项研究等研究的证据,达成一致意见,确定哪种问卷最适合在研究和医疗保健环境中衡量疲劳,这将是有价值的。本研究比较了一种名为 PROMIS 疲劳(MS)8a 的问卷,在本摘要中简称 PROMIS MS 疲劳简短形式,以及两种最常用的问卷:疲劳严重程度量表(FSS)和改良疲劳影响量表(MFIS)。比较这些问卷,以确定应向医生推荐哪种问卷来衡量 MS 患者的疲劳。
结果发现,虽然这三种问卷都很好,但 PROMIS MS 疲劳简短形式问卷在显示 MS 患者之间的疲劳程度差异方面优于另外两种问卷。与疲劳严重程度量表(FSS)相比,PROMIS MS 疲劳简短形式问卷在显示 MS 患者的疲劳水平变化方面也更好。PROMIS MS 疲劳简短形式问卷可能有助于 MS 患者更好地向医生传达他们的疲劳挑战。
该研究表明,PROMIS MS 疲劳简短形式问卷是医生和 MS 患者衡量疲劳的有用工具。